Visualitzant per títol

Phase I, open-label, multicentre study of buparlisib in combination with temozolomide or with concomitant radiation therapy and temozolomide in patients with newly diagnosed glioblastoma

Wen, Patrick Yung; Rodon Ahnert, Jordi; Mason, Warren; Beck, Joseph T; DeGroot, John; Donnet, Valerie (BMJ, 2020-07)

Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors

Luke, Jason; Fakih, Marwan; Schneider, Charles; Chiorean, E. Gabriela; Bendell, Johanna; Kristeleit, Rebecca; Brana, Irene (Springer Nature, 2023-06)

Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)

Gaspar, N.; Campbell Hewson, Quentin; Gallego Melcón, Soledad; Locatelli, F.; Venkatramani, R.; Hecker-Nolting, S. (Elsevier, 2021-10)

Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies

Tan, Daniel S. W.; Martin, Miguel; Ochoa de Olza Amat, Maria; Sarantopoulos, John; Carvajal, Richard; Schoffski, Patrick (BMJ, 2022-02)

Phase I/IIa, open-label, multicentre study to evaluate the optimal dosing and safety of ODM-203 in patients with advanced or metastatic solid tumours

Bono, Petri; Massard, Christophe; Peltola, Katriina J; Azaro Pedrazzoli, Analía Beatriz; Italiano, Antoine; Kristeleit, Rebecca S; Rodon Ahnert, Jordi (BMJ, 2020-12)

Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer

Jhaveri, Komal; Loi, Sherene; Bardia, Aditya; Bellet Ezquerra, Meritxell; Turner, Nicholas; Boni, valentina (American Association for Cancer Research, 2024-02-15)

Phase Ib/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non–small cell lung cancer

Santoro, Armando; Su, Wu-Chou; Navarro Mendivil, Alejandro; Yang, James C. H.; Ardizzoni, Andrea; Felip Font, Enriqueta; Simonelli, Matteo (Elsevier, 2022-04)

Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal Cancer

Yaeger, Rona; Siu, Lillian; Ducreux, Michel; Van Cutsem, Eric; DELORD, Jean-Pierre; Tabernero, Josep; Elez, Elena (Oxford University Press, 2023-12)

Phase II multicohort study of atezolizumab monotherapy in multiple advanced solid cancers

Tabernero Caturla, Josep; André, Fabrice; Bustillos, A.; Fear, S.; Ganta, S.; Blay, Jean-Yves (Elsevier, 2022-04)

Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability–High/Mismatch Repair–Deficient Metastatic Colorectal Cancer: KEYNOTE-164

Le, Dung T.; Kim, Tae Won; Van Cutsem, Eric; Geva, Ravit; Jäger, Dirk; Hara, Hiroki; Elez Fernandez, Mª Elena (American Society of Clinical Oncology, 2020-01-01)

Phase II randomized trial of capecitabine with bevacizumab and external beam radiation therapy as preoperative treatment for patients with resectable locally advanced rectal adenocarcinoma: long term results

Salazar, Ramón; Manzano, Jose Luis; Pericay, Carles; Martínez-Villacampa, Mercedes; López Gil, Carlos; Capdevila Castillon, Jaume (BMC, 2020-11-27)

Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma

Rüschoff, Josef; Lolkema, Martijn; GIANNI, LUCA; Voest, Emile; de Vries, Elisabeth; Tabernero, Josep (Wiley, 2023-06)

Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO)

Levy, Benjamin; Barlesi, Fabrice; Paz-Ares, Luis; Bennouna, Jaafar; Erman, Mustafa; Felip Font, Enriqueta; Isla, Dolores (Elsevier, 2022-04)

Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer

Lara, Pedro C; Rodríguez Melcón, Juan Ignacio; Palacios, Amalia; Lozano, Antonio; Hervás Morón, Asunción; Villafranca, Elena; Maldonado Pijoan, Javier (Frontiers Media, 2022-07-26)

Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer

O'Malley, David M.; Oaknin Benzaquen, Ana Mazaltob; Monk, Bradley J.; Selle, Frédéric; Rojas, Carlos; Gladieff, Laurence (Elsevier, 2021-11)

Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05)

Simó, Marta; Massuti, Bartomeu; Juan, Oscar; Huidobro, Gerardo; FELIP, ENRIQUETA; Nadal, Ernest; Rodriguez-Abreu, Delvys (American Society of Clinical Oncology, 2023-10-01)

Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer

Gulley, James L.; Borre, Michael; Vogelzang, Nicholas J.; Ng, Siobhan; Parker, Chris C.; Carles Galceran, Joan; Agarwal, Neeraj (American Society of Clinical Oncology, 2019-05-01)

Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I

Moore, Kathleen N; Oza, Amit M.; Oaknin Benzaquen, Ana Mazaltob; Lorusso, Domenica; Scambia, Giovanni; Colombo, Nicoletta (Elsevier, 2021-06)

Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)

Pickkers, Peter; Angus, Derek; Bass, Kristie; Bellomo, Rinaldo; van den Berg, Erik; Bernholz, Juliane; Ferrer, Ricard (Springer, 2024-01)

Phenotypic and Genotypic Antimicrobial Susceptibility Testing of Chlamydia trachomatis Isolates from Patients with Persistent or Clinical Treatment Failure in Spain

Boga, Jose Antonio; Vazquez, Fernando; Milagro Beamonte , Ana ; Vall-Mayans, Marti; VILLA, LAURA; Otero, Luis; Salmeron, Paula (MDPI, 2023-05-28)

Scientia. Dipòsit d'Informació Digital del Departament de Salut